Paking, Insahaya .
HRN: 26-61-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFTAZIDIME 1GM (VIAL)
01/28/2025
02/03/2025
IV
2gm
Q8
CAP PTB; T/C Emypema
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes